InsideTrading SEC Form 4 insider trades

Stocks

ENGN enGene Therapeutics Inc.

Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $161.5M

–

Bought and sold by quarter, last 5 years

Open-market purchases and sales by this company's insiders, in dollars, last 5 years

Quarterly insider purchases and sales 2022-Q1: bought $0, sold $0 2022-Q2: bought $0, sold $0 2022-Q3: bought $0, sold $0 2022-Q4: bought $0, sold $0 2023-Q1: bought $0, sold $0 2023-Q2: bought $0, sold $0 2023-Q3: bought $0, sold $0 2023-Q4: bought $149.3K, sold $0 2024-Q1: bought $0, sold $0 2024-Q2: bought $0, sold $788.0K 2024-Q3: bought $2.5M, sold $0 2024-Q4: bought $5.5M, sold $0 2025-Q1: bought $0, sold $0 2025-Q2: bought $0, sold $0 2025-Q3: bought $0, sold $0 2025-Q4: bought $0, sold $0 2026-Q1: bought $0, sold $0 2026-Q2: bought $0, sold $0 2026-Q3: bought $10.1K, sold $0 2026-Q4: bought $0, sold $0
Bought, above the line (largest quarter $5.5M) Sold, below the line (largest quarter $788.0K)
Quarterly insider purchases and sales
QuarterBoughtSold
2022-Q1$0$0
2022-Q2$0$0
2022-Q3$0$0
2022-Q4$0$0
2023-Q1$0$0
2023-Q2$0$0
2023-Q3$0$0
2023-Q4$149.3K$0
2024-Q1$0$0
2024-Q2$0$788.0K
2024-Q3$2.5M$0
2024-Q4$5.5M$0
2025-Q1$0$0
2025-Q2$0$0
2025-Q3$0$0
2025-Q4$0$0
2026-Q1$0$0
2026-Q2$0$0
2026-Q3$10.1K$0
2026-Q4$0$0

Insider activity

Download CSV Up to 5,000 rows
Bought$8.1M14 buy days
Sold$788.0K3 sell days
Net insider flow+$7.3Mnet buying · 5 years
Latest trade2026-09-22Grossman William
Insider trades for this stock
Date Side Insider Role Shares Avg price Value Trades
2026-09-22 Buy Grossman William Other C-suite 5,102 $1.97 $10.1K 1
2024-10-30 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 561,797 $8.90 $5.0M 1
2024-10-08 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 800 $6.60 $5.3K 1
2024-10-07 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 11,844 $6.55 $77.6K 1
2024-10-04 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 5,997 $6.54 $39.2K 1
2024-10-03 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 5,769 $6.48 $37.4K 1
2024-10-02 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 10,153 $6.37 $64.7K 1
2024-10-01 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 35,279 $6.44 $227.2K 1
2024-09-30 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 341,332 $6.34 $2.2M 1
2024-09-27 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 41,639 $5.97 $248.8K 2
2024-09-27 Buy Cooper Ronald Harold Wilfred CEO 10,000 $5.70 $57.0K 1
2024-04-22 Sell FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner 47,854 $15.00 $717.8K 1
2024-04-19 Sell FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner 100 $15.00 $1.5K 1
2024-04-18 Sell FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner 4,575 $15.01 $68.7K 1
2023-12-29 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 10,020 $9.06 $90.8K 2
2023-12-28 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 5,050 $7.69 $38.8K 1
2023-12-27 Buy Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner 2,750 $7.17 $19.7K 1

Who the insiders are, last 5 years

Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.

Insiders of this company with their purchases and sales
Insider Role Bought Sold Last trade
Forbion Growth Opportunities Fund I Cooperatief U.A. 10% owner $8.0M $0 2024-10-30
FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 10% owner $0 $788.0K 2024-04-22
Cooper Ronald Harold Wilfred CEO $57.0K $0 2024-09-27
Grossman William Other C-suite $10.1K $0 2026-09-22

Past buying clusters

A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.

No buying cluster has formed at this company.

Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.